Multienzyme‐Like Nanozyme Encapsulated Ocular Microneedles for Keratitis Treatment
Small · 2024-05 · 20 (21)
DOI: 10.1002/smll.202308403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 15.12.2023. Verfasst von Shen Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials Science and Engineering, Qingdao University of Science and Technology, 53 Zhengzhou Road, Qingdao, Shandong, 266042, China. Hauptthemen laut MEDLINE: Keratitis, Needles. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Keratitis, an inflammation of the cornea caused by bacterial or fungal infections, is one of the leading causes of severe visual disability and blindness. Keratitis treatment requires both the prevention of infection and the reduction of inflammation. However, owing to their limited therapeutic functions, in addition to the ocular barrier, existing conventional medications are characterized by poor efficacy and low bioavailability, requiring high dosages or frequent topical treatment, which represents a burden on patients and increases the risk of side effects. In this study, manganese oxide nanocluster‐decorated graphdiyne nanosheets (MnO x /GDY) are developed as multienzyme‐like nanozymes for the treatment of infectious keratitis and loaded into hyaluronic acid and polymethyl methacrylate‐based ocular microneedles (MGMN). MGMN not only exhibits antimicrobial and anti‐inflammatory effects owing to its multienzyme‐like activities, including oxidase, peroxidase, catalase, and superoxide dismutase mimics but also crosses the ocular barrier and shows increased bioavailability via the microneedle system. Moreover, MGMN is demonstrated to eliminate pathogens, prevent biofilm formation, reduce inflammation, alleviate ocular hypoxia, and promote the repair of corneal epithelial damage in in vitro, ex vivo, and in vivo experiments, thus providing a better therapeutic effect than commercial ophthalmic voriconazole, with no obvious microbial resistance or cytotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Materials Science and Engineering, Qingdao University of Science and Technology, 53 Zhengzhou Road, Qingdao, Shandong, 266042, China.
- College of Chemical Engineering, Qingdao University of Science and Technology, 53 Zhengzhou Road, Qingdao, Shandong, 266042, China.
- Central Laboratory, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China.
ORCID-Profile: Zhiling Zhu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Liu, S., Bai, Q., Jiang, Y., Gao, Y., Chen, Z., Shang, L., Zhang, S., Yu, L., Yang, D., Sui, N., & Zhu, Z. (2024). Multienzyme‐Like Nanozyme Encapsulated Ocular Microneedles for Keratitis Treatment. Small, 20(21). https://doi.org/10.1002/smll.202308403
Vancouver
Liu S, Bai Q, Jiang Y, Gao Y, Chen Z, Shang L, et al. Multienzyme‐Like Nanozyme Encapsulated Ocular Microneedles for Keratitis Treatment. Small. 2024;20(21). doi:10.1002/smll.202308403
BibTeX
@article{Liu2024,
author = {Liu, Shen and Bai, Qiang and Jiang, Yujie and Gao, Yonghui and Chen, Zhen and Shang, Limin and Zhang, Siying and Yu, Linrong and Yang, Dongqin and Sui, Ning and Zhu, Zhiling},
title = {Multienzyme‐Like Nanozyme Encapsulated Ocular Microneedles for Keratitis Treatment},
journal = {Small},
year = {2024},
volume = {20},
number = {21},
doi = {10.1002/smll.202308403}
}
EUVIMED